Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 8.4% in May

Ainos, Inc. (NASDAQ:AIMDGet Free Report) was the target of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 89,900 shares, a drop of 8.4% from the May 15th total of 98,100 shares. Currently, 3.0% of the shares of the company are sold short. Based on an average daily trading volume, of 1,020,000 shares, the short-interest ratio is currently 0.1 days.

Ainos Trading Up 20.0 %

NASDAQ AIMD opened at $1.02 on Wednesday. The company has a fifty day simple moving average of $0.99 and a two-hundred day simple moving average of $1.35. Ainos has a 12-month low of $0.77 and a 12-month high of $6.10. The company has a quick ratio of 0.28, a current ratio of 0.32 and a debt-to-equity ratio of 0.10.

Ainos (NASDAQ:AIMDGet Free Report) last issued its earnings results on Monday, May 13th. The company reported ($0.57) earnings per share (EPS) for the quarter. Ainos had a negative return on equity of 55.38% and a negative net margin of 15,348.14%. The business had revenue of $0.02 million for the quarter.

About Ainos

(Get Free Report)

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.

See Also

Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with's FREE daily email newsletter.